Data collected during the Bridge period will help policymakers assess utilization, cost-effectiveness, and clinical outcomes
At the same time, the drug development horizon is full of promising directions: oral formulations, multi-agonists, longer-acting molecules, and the emergence of biomarkers to personalize therapy
Bray, R
Zepbound, for example, is FDA-approved for adults with obesity or overweight with at least one weight-related condition, in addition to nutrition and activity changes
Aaron Shapiro offer GLP-1 weight loss treatments personalized to each patients health profile and goals
Our medical weight loss program helps patients find the medication that best fits their individual situation, including injections, appetite suppressants, and more